Acuta Capital Partners, LLC Mersana Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

$98.8 Million
Q3 2024

A detailed history of Acuta Capital Partners, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 1,200,000 shares of MRSN stock, worth $2.66 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

1,200,000

Previous 1,663,000 27.84%

Holding current value

$2.66 Million

Previous $3.34 Million 32.14%

% of portfolio

2.3%

Previous 3.6%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.23 - $2.25 $569,490 - $1.04 Million	-463,000 Reduced 27.84%	1,200,000 $2.27 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $4.45 $1 Million - $2.23 Million	-501,628 Reduced 23.17%	1,663,000 $3.34 Million
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $439,283 - $1.21 Million	-203,372 Reduced 8.59%	2,164,628 $9.7 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $2.52 Million - $5.31 Million	2,268,393 Added 2277.34%	2,368,000 $5.49 Million
Q3 2023 Nov 14, 2023	BUY	$1.06 - $3.91 $105,583 - $389,463	99,607 New	99,607 $126,000
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $3.56 Million - $6.25 Million	-890,000 Reduced 93.68%	60,000 $246,000
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $5.37 Million - $7.47 Million	950,000 New	950,000 $5.57 Million
Q2 2021 Aug 16, 2021	SELL	$13.28 - $18.07 $4.75 Million - $6.46 Million	-357,689 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $5.15 Million - $8.92 Million	-336,311 Reduced 48.46%	357,689 $5.79 Million
Q4 2020 Feb 16, 2021	BUY	$16.84 - $27.59 $446,260 - $731,135	26,500 Added 3.97%	694,000 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$16.2 - $25.7 $567,000 - $899,500	35,000 Added 5.53%	667,500 $12.4 Million
Q2 2020 Aug 14, 2020	SELL	$5.24 - $23.4 $1.02 Million - $4.56 Million	-195,000 Reduced 23.56%	632,500 $14.8 Million
Q1 2020 May 15, 2020	BUY	$4.41 - $9.28 $3.65 Million - $7.68 Million	827,500 New	827,500 $4.82 Million

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account

Acuta Capital Partners, LLC Mersana Therapeutics, Inc. Transaction History